In contrast to the vehicle group, the TB001-treated group exhibited markedly reduced infiltration of inflammatory cells and fibrotic areas
10 Metabolic syndrome The metabolic syndrome (MetS) is a common complication of overweight/obesity, leading to T2DM and cardiovascular disease
Beyond cardiovascular health, Aon observed that female GLP-1 users had an approximately 50 percent lower incidence rate for ovarian cancer and 14 percent lower incidence of breast cancer compared to matched female non-users
Subpopulation analysis in STEP 1, which involved only non-diabetic obese patients, revealed that weekly GLP1/GIP medication eliminated 6.99 kg and 0.27 kg more total and visceral fat mass, respectively, than placebo as measured by dual emission X-ray absorptiometry
1 in 3 for women), according to the International Osteoporosis Foundation